# An Open-label Study to Assess the Safety and Effectiveness of AA4500 in Combination With the ErecAid® Esteem® Manual Vacuum Therapy System in Treating Men With Peyronie's Disease

> **NCT02267460** · PHASE3 · COMPLETED · sponsor: **Endo Pharmaceuticals** · enrollment: 30 (actual)

## Conditions studied

- Peyronie's Disease

## Interventions

- **BIOLOGICAL:** AA4500
- **DEVICE:** ErecAid® Esteem® Manual Vacuum Therapy System
- **PROCEDURE:** Investigator Modeling

## Key facts

- **NCT ID:** NCT02267460
- **Lead sponsor:** Endo Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-10
- **Primary completion:** 2015-10
- **Final completion:** 2016-03
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2017-11-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02267460

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02267460, "An Open-label Study to Assess the Safety and Effectiveness of AA4500 in Combination With the ErecAid® Esteem® Manual Vacuum Therapy System in Treating Men With Peyronie's Disease". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02267460. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*